| Tumor microenvironments direct the recruitment and expansion of human Th17 cells X Su, J Ye, EC Hsueh, Y Zhang, DF Hoft, G Peng The Journal of Immunology 184 (3), 1630-1641, 2010 | 425 | 2010 |
| Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, ... Nature communications 9 (1), 1250, 2018 | 220 | 2018 |
| Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer L D’Amico, S Mahajan, AH Capietto, Z Yang, A Zamani, B Ricci, ... Journal of Experimental Medicine 213 (5), 827-840, 2016 | 155 | 2016 |
| Stromal-initiated changes in the bone promote metastatic niche development X Luo, Y Fu, AJ Loza, B Murali, KM Leahy, MK Ruhland, M Gang, X Su, ... Cell reports 14 (1), 82-92, 2016 | 130 | 2016 |
| Human tumor‐infiltrating Th17 cells have the capacity to differentiate into IFN‐γ+ and FOXP3+ T cells with potent suppressive function J Ye, X Su, EC Hsueh, Y Zhang, JM Koenig, DF Hoft, G Peng European journal of immunology 41 (4), 936-951, 2011 | 105 | 2011 |
| The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ... The Journal of Clinical Investigation} 122 (10), 3579-3592, 2012 | 104 | 2012 |
| Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment E Heller, MA Hurchla, J Xiang, X Su, S Chen, J Schneider, KS Joeng, ... Cancer Research 72 (4), 897-907, 2012 | 91 | 2012 |
| Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases MH Ross, AK Esser, GC Fox, AH Schmieder, X Yang, G Hu, D Pan, X Su, ... Cancer research 77 (22), 6299-6312, 2017 | 83 | 2017 |
| Antagonizing integrin β3 increases immunosuppression in cancer X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ... Cancer research 76 (12), 3484-3495, 2016 | 77 | 2016 |
| Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer N Kotagiri, ML Cooper, M Rettig, C Egbulefu, J Prior, G Cui, P Karmakar, ... Nature communications 9 (1), 275, 2018 | 68 | 2018 |
| CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ... Molecular cancer therapeutics 14 (11), 2473-2485, 2015 | 63 | 2015 |
| Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment X Su, Y Xu, GC Fox, J Xiang, KA Kwakwa, JL Davis, JI Belle, WC Lee, ... The Journal of clinical investigation 131 (20), 2021 | 61 | 2021 |
| Inhibition of the stromal p38MAPK/MK2 pathway limits breast cancer metastases and chemotherapy-induced bone loss B Murali, Q Ren, X Luo, DV Faget, C Wang, RM Johnson, T Gruosso, ... Cancer research 78 (19), 5618-5630, 2018 | 59 | 2018 |
| Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation C Yang, JL Davis, R Zeng, P Vora, X Su, LI Collins, S Vangveravong, ... Cancer discovery 3 (2), 212-223, 2013 | 53 | 2013 |
| CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade Y Sato, JK Bolzenius, AM Eteleeb, X Su, CA Maher, JK Sehn, VK Arora JCI insight 3 (23), 2018 | 46 | 2018 |
| Hepatic lipids promote liver metastasis Y Li, X Su, N Rohatgi, Y Zhang, JR Brestoff, KI Shoghi, Y Xu, ... JCI insight 5 (17), 2020 | 40 | 2020 |
| Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types SR Amend, WC Wilson, L Chu, L Lu, P Liu, D Serie, X Su, Y Xu, D Wang, ... PloS one 10 (5), e0127828, 2015 | 39 | 2015 |
| Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer AK Esser, MH Ross, F Fontana, X Su, A Gabay, GC Fox, Y Xu, J Xiang, ... Theranostics 10 (17), 7510, 2020 | 31 | 2020 |
| Targeted therapy to β3 integrin reduces chemoresistance in breast cancer bone metastases GC Fox, X Su, JL Davis, Y Xu, KA Kwakwa, MH Ross, F Fontana, J Xiang, ... Molecular cancer therapeutics 20 (6), 1183-1198, 2021 | 22 | 2021 |
| Research Network TCGA, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556, 2017 | 22 | 2017 |
